Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial (Q39251042)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial |
scientific article |
Statements
1 reference
Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial (English)
1 reference
Daniel Podzamczer
1 reference
Gerd Fätkenheuer
1 reference
Keikawus Arastéh
1 reference
Jan van Lunzen
1 reference
Bonaventura Clotet
1 reference
Babafemi Taiwo
1 reference
Giuseppe Pantaleo
1 reference
Jürgen K Rockstroh
1 reference
Margaret Fischl
1 reference
Richard B Pollard
1 reference
David M Asmuth
1 reference
Barry Peters
1 reference
Felipe Garcia
1 reference
Kim Ellefsen
1 reference
Dirk Schürmann
1 reference
W David Hardy
1 reference
Ronald Mitsuyasu
1 reference
Graeme Moyle
1 reference
Andreas Plettenberg
1 reference
Martin Fisher
1 reference
Ingebjørg Baksaas
1 reference
Darren Jolliffe
1 reference
Stefan Persson
1 reference
Oyvind Jelmert
1 reference
Arnt-Ove Hovden
1 reference
Maja A Sommerfelt
1 reference
Vidar Wendel-Hansen
1 reference
Birger Sørensen
1 reference
11 February 2014
1 reference
1 reference
14
1 reference
4
1 reference
291-300
1 reference
Identifiers
1 reference
1 reference